Session 4: Making a case - ROI and business case for tobacco control

Similar documents
Health Economics South West Webinar Series 12 October 2015 Rebecca Worboys presenting Nicola Bowtell Facilitating Dominic Gallagher Facilitating

Smoking and Rheumatoid Arthritis: how to deliver brief smoking cessation advice

Quit & Get Fit! Frequently Asked Questions For Personal Trainers (November 2011)

Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15

Improving smoking cessation in drug and alcohol treatment

1.1 WHAT IS A QUIT LINE?

Health Improvement Performance Management for the National Health Service in Scotland

Supporting investment in public health: Review of methods for assessing cost effectiveness, cost impact and return on investment

Tobacco Taxation in New Zealand

Assessing and Forecasting Population Health

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s)

ISSUEBrief. Reducing the Burden of Smoking on Employee Health and Productivity. Center for Prevention

Guidance on standards for training in smoking cessation practice in Wales


NHS Whittington Health/ Smokefree Islington <Enter date>

Alcohol abuse and smoking

Non-Communicable Diseases and Occupational Health Opportunities and Challenges

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS

Healthcare provider cessation practices in Ontario. Alexey Babayan Knowledge Exchange Forum June 18, 2014

Beyond Meaningful Use -- Multi- disciplinary Team Integration of Customized Smoking Cessation Patient Education Into EMR Clinical Decision Support

What are the PH interventions the NHS should adopt?

Changing the way smoking is measured among Australian adults: A preliminary investigation of Victorian data

The American Cancer Society Cancer Prevention Study I: 12-Year Followup

New Jersey Department of Health. Office of Tobacco Control, Nutrition and Fitness. Request for Applications (RFA)#2

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

Health risk assessment: a standardized framework

A guide to social return on investment for alcohol and drug treatment commissioners

Cost-effectiveness of dimethyl fumarate (Tecfidera ) for the treatment of adult patients with relapsing remitting multiple sclerosis

Connection with other policy areas and (How does it fit/support wider early years work and partnerships)

Health and Longevity. Global Trends. Which factors account for most of the health improvements in the 20th century?

1. Comparative effectiveness of alemtuzumab

4. Does your PCT provide structured education programmes for people with type 2 diabetes?

Assessing and Forecasting Population Health

The economic burden of obesity

RAND Data: An Example of Population Management. Trina Dutta, MPP, MPH

SMOKING TOBACCO: SMOKING

Jamie Brown, University College London

Tobacco Cessation Update. Teleconference September 29, 2015

Improving the Delivery of End of Life Care

Terminal illness pricing considerations. Steve Varney

Transforming Healthcare

Deaths from Respiratory Diseases: Implications for end of life care in England. June

A Population Health Management Approach in the Home and Community-based Settings

Screening for asbestos-related lung cancer Nea Malila, Tony Miller, Riitta Sauni, Robert Smith, Kurt Straif, Tapio Vehmas

2014 Assessment of Smoking Policies and Practices in Residential and Outpatient Treatment Facilities in Sonoma County

Butler Memorial Hospital Community Health Needs Assessment 2013

Measuring Outcomes for NC Local Health Departments: Preliminary Results

Brief Interventions for other drugs? Luke Mitcheson, Clinical Psychologist,

UPDATE ON SMOKING COSTS TO SOCIETY


Risk factors and public health in Denmark Summary report

East Sussex LAA Delivery Plan

Overarching Logic Model: Treating Tobacco Addiction. Outcomes-Impact Inputs. Activities. Long

Education Surveys and Trends for

Defining policy-relevant indicators to evaluate regional injury prevention initiatives

National Standard for Tobacco Cessation Support Programme

STATEMENT ON ESTIMATING THE MORTALITY BURDEN OF PARTICULATE AIR POLLUTION AT THE LOCAL LEVEL

Commissioning Strategy

What is costeffectiveness?

STATS WINDOW. INDUSTRY REVIEW AT A GLANCE Global Pharmaceutical Industry

What influences managers ability to record and report on non-financial capitals? The case of Social Return on Investment

Moving toward a Tobacco-Free Nova Scotia

Strategies for cancer care in Sweden

On-line training in support of smoking cessation

Basic Study Designs in Analytical Epidemiology For Observational Studies

Workforce capacity planning model

Tobacco Free Campuses: Conveying the Message

Health in Camden. Camden s shadow health and wellbeing board: joint health and wellbeing strategy 2012 to 2013

Formulating Clinical Questions. Keith Posley, MD Lauren Maggio, MS

Prevention and Wellness Advisory Board August 19, Cheryl Bartlett, RN Commissioner Massachusetts Department of Public Health

Corporate Wellness Programs

Case-control studies. Alfredo Morabia

Costing statement: Depression: the treatment and management of depression in adults. (update) and

Cost-Benefit and Cost-Effectiveness Analysis. Kevin Frick, PhD Johns Hopkins University

An introduction to impact measurement

Social Return on Investment

Corporate Wellness Programs A Guide to Strategic Design

The Burden of Occupational Lung Cancer Paul A. Demers, PhD

The Effects of Increasing Tobacco Taxation: A Cost Benefit and Public Finances Analysis

Obesity: The Business Case for Intervention

Measuring quality along care pathways

EMR in Support of Smoking Cessation Counseling March 3, 2016

Achieving Quality and Value in Chronic Care Management

CHRONIC DISEASE COST CALCULATOR USER GUIDE. Version 2. November Centers for Disease Control and Prevention (CDC)

Section 8» Incidence, Mortality, Survival and Prevalence

The demand for cigarettes and other tobacco products. Anne-Marie Perucic Tobacco Control Economics Tobacco Free Initiative WHO

The Evaluation of Cancer Control Interventions in Lung Cancer Using a Canadian Cancer Risk Management Model

The decision making process and the application of value judgments. Francis Ruiz Senior Adviser (Health Economics) NICE International April 2014

Performance Monitoring for Primary Health Networks:

VISION MISSION GOAL AND OBJECTIVES

29 June 2016 PHE Gateway number: Dear Colleague, Re: Children s public health 0-5 years review of mandation

INDIA. Overview: National Cancer Control Programme

NETWORK IMPLEMENTATION GUIDE

Monitoring and measuring change in market systems -rethinking the current paradigm-

MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING

Better Living with Obstructive Pulmonary Disease A Patient Guide

HOW TO STOP SMOKING. Dr Coral Gartner UQ Centre for Clinical Research

Exploring the potential of trans fats policies to reduce socio-economic inequalities in coronary heart disease mortality in England

RR833. The joint effect of asbestos exposure and smoking on the risk of lung cancer mortality for asbestos workers ( )

Chapter 7: Effect Modification

Transcription:

Session 4: Making a case - ROI and business case for tobacco control ARCH Technical Workshop Bali August 2014 Matt Glover Health Economics Research Group Brunel University London

Session outline What does ROI mean? Why do we need to know ROI of tobacco control? Introduction to NICE Tobacco ROI tool An example of a business case based on NICE tool

Return on investment ROI Umbrella term used to refer to the return that investing in tobacco control agendas could generate Primarily economic concept (Does my $1 investment give me >$1 benefit?) Wider consequences are being included, not necessarily monetised - SROI

Why ROI matters

NICE Tobacco return on investment tool www.nice.org.uk/about/what-we-do/into-practice/return-on-investment-tools/tobacco-return-oninvestment-tool

NICE Tobacco ROI tool Scope: Develop a toolkit that would estimate economic impact of broader tobacco control (not limited to cessation interventions) A user friendly version that would generate outputs for different geographical area (e.g. LA, county and region) Timing - challenging: Provision and funding of public health undergoing major changes Anecdotal evidence suggests smoking prevalence is falling at a lower rate during recession Need to ensure that tobacco control and smoking cessation remain a public health priority

Limitations of previous analyses Disparate estimates of the burden Differences in scope/perspective i.e. inclusion of indirect costs such as productivity costs Differences in conditions included and attributable fractions applied Intended to inform national debate on tobacco control Dominated by estimates of lifetime/long-term impact with minimal resonance for local decision makers Small area level analysis limited (Callum et al. 2005)

NICE ROI Tool Microsoft Excel based Markov model Begins with total population in selected area Current smokers, ex-smokers, never smokers Interventions may help current smokers to quit but they may relapse too Current smokers are followed for their lifetime to track changes in mortality, health service use, and productivity Cost and QALYs are estimated accordingly

Aim of the tool To explore the economic case for comprehensive tobacco control strategies Build on the best available evidence on tobacco control Suitable for use by health and local authorities Include health and non-health outcomes Include financial and non-financial consequences

Development of the model Attempt to build on previous analyses (e.g. Flack, Taylor & Trueman 2007) Incremental improvements: Improved granularity of metrics Incorporate uptake and passive smoking effects Capture selected non-health outcomes Improve interactivity to facilitate bespoke local level analyses

The economic model A Microsoft Excel based model to assist planners and commissioners involved in public health Markov model, following a cohort of current smokers over their lifetime to identify costs and outcomes Results are expressed in four time horizons: 2 years (short term) 5 years 10 years Lifetime

Markov process Smokers Former Smokers Death Considers cohort of current smokers Each year they become Current smokers Former smokers Die Health outcomes and resource use driven by smoking status

The model ingredients Smokers and former smokers each have a risk of developing a number of smoking attributable conditions & death CVD, MI, COPD, lung cancer Healthcare resource use, QOL/utility and productivity also dependent on smoking status Data sourced from widely accepted stats/literature

How the model works Model pre-populated with default data, although this can be easily over-written to reflect local knowledge/data Model categorises local population as never-smokers, current smokers or former smokers Current smokers continue to smoke or move to former smokers each year, reflecting quit rates Individuals exit the model as a result of death

Business case scenarios Using the tool to build a business case How much is tobacco costing (Baseline scenario)? How much does your Current Package of interventions cost you? What are the benefits of the Current Package? Are there any savings to be made by local businesses, health and social care sectors as well as by people who don't smoke (passive smokers)?

Business case scenarios Using the tool to build a business case Does the benefit outweigh the costs? If so, at what time point? What is the ROI of the Current Package? To what extent can the savings made by local businesses pay for investment in the Current Package? At what time point can the investment in cessation programmes pay for itself? What potential improvements could you make by altering your current service provision (Alternative Package)?

Practical example Making Business Cases for: Current practice (i.e. the existing provision) Practice variation (i.e. doing things differently) Discussion to be based on handouts: 1) Report of current practice 2) Report of alternative practice